Advancing mesenchymal stem cell therapy for asthma towards clinical translation.

Ann Transl Med · 2022 · PMC9652520 · PMID 36388842

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

clearly significantno p-value reported

have pointed out, there is clearly significant potential for the application of MSCs and their by-products in the treatment of asthma however the next steps need to involve a multidisciplinary approach to advancing towards an increased number of human trials.

also in 627 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.